US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist

0.746
-0.006-0.82%

Close Jul 5 16:00 ET

0.750
+0.005+0.60%

Post 19:42 ET

52.89MMarket Cap-1035P/E (TTM)

Ovid Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

124.24%148K

-73.93%391.7K

205.88%141.56K

881.55%108.97K

75K

-95.43%66K

-99.28%1.5M

46.28K

11.1K

Operating revenue

124.24%148K

-73.93%391.7K

205.88%141.56K

881.55%108.97K

--75K

-95.43%66K

-99.28%1.5M

--46.28K

--11.1K

--0

Cost of revenue

Gross profit

Operating expense

17.43%17.57M

4.60%59.67M

50.02%18.33M

-5.29%12.14M

-0.40%14.25M

-15.55%14.96M

-32.22%57.05M

-53.63%12.22M

9.71%12.82M

-0.07%14.3M

Selling and administrative expenses

-14.08%7.17M

-4.15%31.09M

15.40%7.69M

-10.84%6.81M

-0.11%8.25M

-15.56%8.34M

-12.89%32.43M

-19.36%6.66M

12.83%7.63M

24.54%8.26M

-General and administrative expense

-14.08%7.17M

-4.15%31.09M

15.40%7.69M

-10.84%6.81M

-0.11%8.25M

-15.56%8.34M

-12.89%32.43M

-19.36%6.66M

12.83%7.63M

24.54%8.26M

Research and development costs

57.17%10.4M

16.12%28.59M

91.53%10.64M

2.88%5.33M

-0.79%6M

-15.54%6.62M

-47.55%24.62M

-69.29%5.56M

5.41%5.18M

-21.30%6.05M

Operating profit

-16.96%-17.42M

-6.72%-59.28M

-49.42%-18.19M

6.06%-12.03M

0.92%-14.17M

8.45%-14.89M

-144.72%-55.55M

53.81%-12.17M

-9.61%-12.8M

0.07%-14.3M

Net non-operating interest income expense

4.9M

Non-operating interest income

----

--4.9M

----

Other net income (expense)

272.59%5.72M

45.02%2M

-410.75%-2.08M

-7.13%776.45K

720.73%1.76M

634.75%1.54M

3,118.45%1.38M

17,018.19%668.12K

31,367.26%836.09K

-11,188.32%-284.13K

Gain on sale of security

----

--2M

----

Other non- operating income (expenses)

272.59%5.72M

----

-7.13%776.45K

720.73%1.76M

634.75%1.54M

3,118.45%1.38M

17,018.19%668.12K

31,367.26%836.09K

-11,188.32%-284.13K

Income before tax

12.44%-11.69M

3.38%-52.34M

-33.18%-15.32M

5.98%-11.25M

14.94%-12.41M

16.83%-13.36M

-143.63%-54.17M

56.34%-11.5M

-2.47%-11.97M

-1.91%-14.59M

Income tax

Net income

12.44%-11.69M

3.38%-52.34M

-33.18%-15.32M

5.98%-11.25M

14.94%-12.41M

17.08%-13.36M

-144.10%-54.17M

55.75%-11.5M

-5.13%-11.97M

7.60%-14.59M

Net income continuous Operations

12.44%-11.69M

3.38%-52.34M

-33.18%-15.32M

5.98%-11.25M

14.94%-12.41M

17.08%-13.36M

-144.10%-54.17M

55.75%-11.5M

-5.13%-11.97M

7.60%-14.59M

Minority interest income

Net income attributable to the parent company

12.44%-11.69M

3.38%-52.34M

-33.18%-15.32M

5.98%-11.25M

14.94%-12.41M

17.08%-13.36M

-144.10%-54.17M

55.75%-11.5M

-5.13%-11.97M

7.60%-14.59M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

12.44%-11.69M

3.38%-52.34M

-33.18%-15.32M

5.98%-11.25M

14.94%-12.41M

17.08%-13.36M

-145.20%-54.17M

54.26%-11.5M

-5.13%-11.97M

7.60%-14.59M

Basic earnings per share

10.53%-0.17

3.90%-0.74

-37.50%-0.22

5.88%-0.16

14.29%-0.18

17.39%-0.19

-143.26%-0.77

57.89%-0.16

0.00%-0.17

8.70%-0.21

Diluted earnings per share

10.53%-0.17

3.90%-0.74

-37.50%-0.22

5.88%-0.16

14.29%-0.18

17.39%-0.19

-143.75%-0.77

57.89%-0.16

0.00%-0.17

8.70%-0.21

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	124.24%148K	-73.93%391.7K	205.88%141.56K	881.55%108.97K	75K	-95.43%66K	-99.28%1.5M	46.28K	11.1K	0
Operating revenue	124.24%148K	-73.93%391.7K	205.88%141.56K	881.55%108.97K	--75K	-95.43%66K	-99.28%1.5M	--46.28K	--11.1K	--0
Cost of revenue
Gross profit
Operating expense	17.43%17.57M	4.60%59.67M	50.02%18.33M	-5.29%12.14M	-0.40%14.25M	-15.55%14.96M	-32.22%57.05M	-53.63%12.22M	9.71%12.82M	-0.07%14.3M
Selling and administrative expenses	-14.08%7.17M	-4.15%31.09M	15.40%7.69M	-10.84%6.81M	-0.11%8.25M	-15.56%8.34M	-12.89%32.43M	-19.36%6.66M	12.83%7.63M	24.54%8.26M
-General and administrative expense	-14.08%7.17M	-4.15%31.09M	15.40%7.69M	-10.84%6.81M	-0.11%8.25M	-15.56%8.34M	-12.89%32.43M	-19.36%6.66M	12.83%7.63M	24.54%8.26M
Research and development costs	57.17%10.4M	16.12%28.59M	91.53%10.64M	2.88%5.33M	-0.79%6M	-15.54%6.62M	-47.55%24.62M	-69.29%5.56M	5.41%5.18M	-21.30%6.05M
Operating profit	-16.96%-17.42M	-6.72%-59.28M	-49.42%-18.19M	6.06%-12.03M	0.92%-14.17M	8.45%-14.89M	-144.72%-55.55M	53.81%-12.17M	-9.61%-12.8M	0.07%-14.3M
Net non-operating interest income expense		4.9M
Non-operating interest income	----	--4.9M	----	----	----	----	----	----	----	----
Other net income (expense)	272.59%5.72M	45.02%2M	-410.75%-2.08M	-7.13%776.45K	720.73%1.76M	634.75%1.54M	3,118.45%1.38M	17,018.19%668.12K	31,367.26%836.09K	-11,188.32%-284.13K
Gain on sale of security	----	--2M	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	272.59%5.72M	----	----	-7.13%776.45K	720.73%1.76M	634.75%1.54M	3,118.45%1.38M	17,018.19%668.12K	31,367.26%836.09K	-11,188.32%-284.13K
Income before tax	12.44%-11.69M	3.38%-52.34M	-33.18%-15.32M	5.98%-11.25M	14.94%-12.41M	16.83%-13.36M	-143.63%-54.17M	56.34%-11.5M	-2.47%-11.97M	-1.91%-14.59M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	12.44%-11.69M	3.38%-52.34M	-33.18%-15.32M	5.98%-11.25M	14.94%-12.41M	17.08%-13.36M	-144.10%-54.17M	55.75%-11.5M	-5.13%-11.97M	7.60%-14.59M
Net income continuous Operations	12.44%-11.69M	3.38%-52.34M	-33.18%-15.32M	5.98%-11.25M	14.94%-12.41M	17.08%-13.36M	-144.10%-54.17M	55.75%-11.5M	-5.13%-11.97M	7.60%-14.59M
Minority interest income
Net income attributable to the parent company	12.44%-11.69M	3.38%-52.34M	-33.18%-15.32M	5.98%-11.25M	14.94%-12.41M	17.08%-13.36M	-144.10%-54.17M	55.75%-11.5M	-5.13%-11.97M	7.60%-14.59M
Preferred stock dividends
Other preferred stock dividends	0	0	0	0		0	0	0	0
Net income attributable to common stockholders	12.44%-11.69M	3.38%-52.34M	-33.18%-15.32M	5.98%-11.25M	14.94%-12.41M	17.08%-13.36M	-145.20%-54.17M	54.26%-11.5M	-5.13%-11.97M	7.60%-14.59M
Basic earnings per share	10.53%-0.17	3.90%-0.74	-37.50%-0.22	5.88%-0.16	14.29%-0.18	17.39%-0.19	-143.26%-0.77	57.89%-0.16	0.00%-0.17	8.70%-0.21
Diluted earnings per share	10.53%-0.17	3.90%-0.74	-37.50%-0.22	5.88%-0.16	14.29%-0.18	17.39%-0.19	-143.75%-0.77	57.89%-0.16	0.00%-0.17	8.70%-0.21
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall